Orthobond delivers its first OSTAGUARD™ coated implants for surgery
Components will be the first-in-human use of OSTAGUARD™ PRINCETON, N.J. — (BUSINESS WIRE) — Orthobond Corporation, a leader in covalently-bound antibacterial surface technologies with broad applications in the medical device industry, today announced the successful in-house production and commercial delivery